BIORCHESTRA
Developing novel rna-based therapeutics for neuroinflammatory diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$180—270m (Dealroom.co estimates Feb 2022.)
Cambridge Massachusetts (HQ)
Authorizing premium user...